SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-23-001765
Filing Date
2023-07-31
Accepted
2023-07-31 19:38:08
Documents
1
Period of Report
2023-07-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form413531ben_07282023.html 4  
1 OWNERSHIP DOCUMENT form413531ben_07282023.xml 4 8766
  Complete submission text file 0000921895-23-001765.txt   10184
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 44 ZAYT SHEMEN ST. FLAT 4 EFRAT L3 9045544
Business Address
Ben-Tzvi Avraham (Reporting) CIK: 0001944721 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13341 | Film No.: 231129094